Key Conversations and Trusted Information Among Hesitant Adopters of the COVID-19 Vaccine. 2023

Rachel S Purvis, and Ramey Moore, and Don E Willis, and Shashank S Kraleti, and Morgan P Gurel-Headley, and Sheena CarlLee, and Pearl A McElfish
College of Medicine, University of Arkansas for Medical Sciences Northwest, Springdale, Arkansas, USA.

COVID-19 vaccines effectively protect against COVID-19-related hospitalization or death, and 67.1% of the US population is fully vaccinated. However, the disparity in COVID-19 vaccination persists among minority and rural populations who often report greater hesitancy about COVID-19 vaccines. This exploratory study aimed to understand and document trusted sources of information about the COVID-19 vaccine among a diverse sample of hesitant adopters with in-depth interviews. Participants (n = 21) described how information from trusted sources influenced their decision to get a COVID-19 vaccine despite being hesitant. Participants reported health care professionals, family members, friends, coworkers, community leaders, public health experts, government officials, and the mainstream media as trusted sources of information about the COVID-19 vaccines. Participants discussed obtaining trusted information from multiple modes, including direct conversations with trusted messengers and public health communications from public influencers who reinforced the information shared with trusted messengers. Notably, participants discussed having multiple conversations with trusted messengers during their decision-making process, and these trusted messengers often facilitated the participants' vaccination process. Study findings highlight the continued need for clear, understandable information about vaccine side effects, safety, and efficacy to address concerns that contribute to vaccine hesitancy.

UI MeSH Term Description Entries
D005190 Family A social group consisting of parents or parent substitutes and children. Family Life Cycles,Family Members,Family Life Cycle,Family Research,Filiation,Kinship Networks,Relatives,Families,Family Member,Kinship Network,Life Cycle, Family,Life Cycles, Family,Network, Kinship,Networks, Kinship,Research, Family
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086663 COVID-19 Vaccines Vaccines or candidate vaccines containing SARS-CoV-2 component antigens, genetic materials, or inactivated SARS-CoV-2 virus, and designed to prevent COVID-19. 2019 Novel Coronavirus Vaccine,2019 Novel Coronavirus Vaccines,2019-nCoV Vaccine,2019-nCoV Vaccines,COVID 19 Vaccine,COVID-19 Vaccine,COVID-19 Virus Vaccine,COVID-19 Virus Vaccines,COVID19 Vaccine,COVID19 Vaccines,COVID19 Virus Vaccine,COVID19 Virus Vaccines,Coronavirus Disease 2019 Vaccine,Coronavirus Disease 2019 Vaccines,Coronavirus Disease 2019 Virus Vaccine,Coronavirus Disease 2019 Virus Vaccines,Coronavirus Disease-19 Vaccine,Coronavirus Disease-19 Vaccines,SARS Coronavirus 2 Vaccines,SARS-CoV-2 Vaccine,SARS-CoV-2 Vaccines,SARS2 Vaccine,SARS2 Vaccines,2019 nCoV Vaccine,2019 nCoV Vaccines,COVID 19 Vaccines,COVID 19 Virus Vaccine,COVID 19 Virus Vaccines,Coronavirus Disease 19 Vaccine,Coronavirus Disease 19 Vaccines,SARS CoV 2 Vaccine,SARS CoV 2 Vaccines,Vaccine, 2019-nCoV,Vaccine, COVID 19,Vaccine, COVID-19,Vaccine, COVID-19 Virus,Vaccine, COVID19,Vaccine, COVID19 Virus,Vaccine, Coronavirus Disease-19,Vaccine, SARS-CoV-2,Vaccine, SARS2,Vaccines, 2019-nCoV,Vaccines, COVID-19,Vaccines, COVID-19 Virus,Vaccines, COVID19,Vaccines, COVID19 Virus,Vaccines, Coronavirus Disease-19,Vaccines, SARS-CoV-2,Vaccines, SARS2,Virus Vaccine, COVID-19,Virus Vaccine, COVID19,Virus Vaccines, COVID-19,Virus Vaccines, COVID19
D058015 Health Communication The transfer of information from experts in the medical and public health fields to patients and the public. The study and use of communication strategies to inform and influence individual and community decisions that enhance health. Communication, Health,Communications, Health,Health Communications
D033062 Friends Persons whom one knows, likes, and trusts. Friendship,Acquaintances,Companions,Companion,Friend,Friendships

Related Publications

Rachel S Purvis, and Ramey Moore, and Don E Willis, and Shashank S Kraleti, and Morgan P Gurel-Headley, and Sheena CarlLee, and Pearl A McElfish
June 2023, Infectious medicine,
Rachel S Purvis, and Ramey Moore, and Don E Willis, and Shashank S Kraleti, and Morgan P Gurel-Headley, and Sheena CarlLee, and Pearl A McElfish
October 2022, Clinical and translational science,
Rachel S Purvis, and Ramey Moore, and Don E Willis, and Shashank S Kraleti, and Morgan P Gurel-Headley, and Sheena CarlLee, and Pearl A McElfish
May 2024, BMC medical informatics and decision making,
Rachel S Purvis, and Ramey Moore, and Don E Willis, and Shashank S Kraleti, and Morgan P Gurel-Headley, and Sheena CarlLee, and Pearl A McElfish
January 2022, Annals of family medicine,
Rachel S Purvis, and Ramey Moore, and Don E Willis, and Shashank S Kraleti, and Morgan P Gurel-Headley, and Sheena CarlLee, and Pearl A McElfish
February 2024, Journal of community health,
Rachel S Purvis, and Ramey Moore, and Don E Willis, and Shashank S Kraleti, and Morgan P Gurel-Headley, and Sheena CarlLee, and Pearl A McElfish
September 2023, Behavioral medicine (Washington, D.C.),
Rachel S Purvis, and Ramey Moore, and Don E Willis, and Shashank S Kraleti, and Morgan P Gurel-Headley, and Sheena CarlLee, and Pearl A McElfish
October 2023, Journal of health communication,
Rachel S Purvis, and Ramey Moore, and Don E Willis, and Shashank S Kraleti, and Morgan P Gurel-Headley, and Sheena CarlLee, and Pearl A McElfish
April 2023, Journal of behavioral medicine,
Rachel S Purvis, and Ramey Moore, and Don E Willis, and Shashank S Kraleti, and Morgan P Gurel-Headley, and Sheena CarlLee, and Pearl A McElfish
April 2021, Behavioral sciences (Basel, Switzerland),
Rachel S Purvis, and Ramey Moore, and Don E Willis, and Shashank S Kraleti, and Morgan P Gurel-Headley, and Sheena CarlLee, and Pearl A McElfish
March 2024, American journal of health promotion : AJHP,
Copied contents to your clipboard!